Falchi Lorenzo; Nijland Marcel; Huang Huiqiang; Linton Kim M; Seymour John F; Tao Rong; Kwiatek Michal; Costa Abel; Vassilakopoulos Theodoros P; Greil Richard; Jiménez-Ubieto Ana; Gangatharan Shane A; Benjamini Ohad; Thieblemont Catherine; Tucci Alessandra; Elinder-Camburn Anna; Illes Arpad; Novak Jan; Pavlovsky Miguel A; McDonald Andrew; Yoon Dok Hyun; Maruyama Dai; Sunkersett Gauri; Mei Jian P; Mukherjee Nabanita; Zhu Feng; Alshreef Abualbishr; Favaro Elena; Morschhauser Franck; Kollaborációs szervezet: EPCORE FL-1 Investigators; Modok Szabolcs; Mikala Gábor; Masszi András; Rajnics Péter; et al.:
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1) : a global, open-label, randomised, phase 3 trial.
LANCET, 407 (10524).
pp. 161-173.
ISSN 0140-6736
(2026)